Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.3369EUR
−1.97 MEUR
63.02 MEUR
2.77 M
About GREIFFENBERGER AG O.N.
Sector
Industry
Headquarters
Augsburg
Website
Employees (FY)
324
Founded
1986
ISIN
DE0005897300
FIGI
BBG000BCN8Q9
Grifols SA is a Spain-based company engaged in the biopharmaceuticals manufacture. The Company’s activities are divided into four business segments: Bioscience, Hospital, Diagnostic and Raw materials. The Bioscience division focuses on the research, development, manufacturing and marketing of products derived from human plasma for therapeutic use. The Hospital division offers non-biological pharmaceutical products and medical supplies for hospital pharmacy. The Diagnostic division provides clinical analysis and laboratory testing tools to laboratories, hospitals and blood banks. The Raw materials division includes sales of intermediate biological products, as well as manufacturing services to third parties. The Company operates production facilities in Spain, the United States, Mexico and Australia, among others. It controls numerous subsidiaries.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange Greiffenberger AG stocks are traded under the ticker GRF.
Yes, you can track Greiffenberger AG financials in yearly and quarterly reports right on TradingView.
Greiffenberger AG is going to release the next earnings report on Sep 30, 2024. Keep track of upcoming events with our Earnings Calendar.
GRF net income for the last half-year is −1.97 M EUR, while the previous report showed −4.00 K EUR of net income which accounts for −49.13 K% change. Track more Greiffenberger AG financial stats to get the full picture.
No, GRF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 14, 2024, the company has 324.00 employees. See our rating of the largest employees — is Greiffenberger AG on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Greiffenberger AG EBITDA is 2.55 M EUR, and current EBITDA margin is 4.50%. See more stats in Greiffenberger AG financial statements.
Like other stocks, GRF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Greiffenberger AG stock right from TradingView charts — choose your broker and connect to your account.